Brief: Vera Therapeutics FY EPS USD -2.75 Vs. IBES Estimate USD -2.84
26/02/2025 13:25
Feb 26 (Reuters) - Vera Therapeutics FY operating income USD -167.17 million vs. IBES estimate USD -165.9 million. FY net income USD -152.149 million vs. IBES estimate USD -158.7 million FY operating expenses USD 167.17 million
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial